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Background: The mechanisms through which exercise reduces cardiovascular disease are not fully understood. We
used echocardiograms, cardiac biomarkers and gene expression to investigate cardiovascular effects associated with
exercise training.
Methods: Nineteen sedentary men (22–37 years) completed a 17-week half-marathon training program. Serial
measurements of resting heart rate, blood pressure, maximum oxygen consumption, lipids, C-reactive protein,
cardiac troponin T, echocardiograms and blood for gene expression were obtained from baseline to peak training.
Controls included 22 sedentary men who did not exercise.
Results: Among the training group, VO2 max increased from 37.1 to 42.0 ml/kg/min (p < 0.001). Significant changes
were seen in left ventricular wall thickness and mass, stroke volume, resting heart rate and blood pressure (p < 0.001).
The control group demonstrated no significant changes. Expression profiling in the training group identified 10
significantly over-expressed and 53 significantly under-expressed loci involved in inflammatory pathways. Dividing
the training group into high and low responders based on percent change in VO2 max identified loci that
differentiated these two groups at baseline and after training.
Conclusion: Intensive exercise training leads to significant increase in cardiac and hemodynamic performance,
and significant changes in expression of genes involved in immune and inflammatory response.
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Long-term exercise training has been associated with
weight loss, improvements in lipid profile and blood
pressure, and cardiac remodeling [1-3]. Despite this, the
cardiovascular response to high-intensity training in previ-
ously untrained individuals is not well characterized. Im-
portantly, even with extreme marathon and half-marathon
(HM) exercise training, individuals may experience vary-
ing levels of cardiovascular and physiological changes, and
these differences may have a biological basis. For example,* Correspondence: ERampersaud@med.miami.edu
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reproduction in any medium, provided the orHM and marathon training have been associated with
increases in oxidative stress and myocardial damage
[4-9]. HM and marathon training also induces the re-
lease of troponin I and T, markers of myocardial injury;
elevations in cardiac troponin T (cTnT) are reported in
up to 39-56% of athletes immediately after performance
[10]. Although the mechanism and implications are not
well defined, these biomarkers usually return to normal
within 24 to 48 hours, and the magnitude of biomarker
peak is inversely related to the level of training prior to
the event [10]. The purpose of our study was to assess
time-related cardiovascular performance and function
and corresponding gene expression changes in partici-
pants undergoing HM training. Our goal is to begin to
identify a genomic basis for response to exercise bytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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physiologic changes following HM training.
Methods
Apparently healthy, untrained and sedentary males (n = 47),
between 18 and 45 years of age, participated in the study.
Candidates were required to have engaged in less than
2 hours of aerobic training per week prior to enrollment,
have an average maximum oxygen consumption (VO2 max)
less than 50 ml/kg/min, and not previously completed a
HM. Twenty-four of the subjects, who were enrolled in
a local HM Training Program, were recruited into the
training group (TRAIN), and twenty-three male subjects
of similar age were recruited into the control group
(CON). The CON group did not participate in the
training program or undergo any lifestyle modification
over the 16 week duration of the study. All subjects
volunteered for the study and signed informed consents.
TRAIN subjects were compensated for meals, travel time,
and training program fees. Exclusion criteria included
smoking, known metabolic or cardiovascular conditions
(diabetes or dyslipidemia), chronic inflammatory diseases,
or chronic use of non-steroidal anti-inflammatory drugs.
The protocol was approved by the University of Miami
Institutional Review Board for human subjects research.
Initial screening and evaluation included a complete
medical and training history, baseline VO2 max test,
resting heart rate, blood pressure, height, weight, body
composition assessment, serum biomarkers, and complete
echocardiographic evaluation. Body composition was as-
sessed through dual-energy X-ray absorptiometry scan-
ning. Blood for the lipid panels and serum biomarkers was
drawn via the antecubital vein using the LeukoLock Pro-
tection system and stored at −80°C for analyses with the
post-training RNA samples. Lipid panels were done on
fasted blood samples. TRAIN and CON subjects had heart
rate, blood pressure, height, weight, and serum biomarkers
repeated at 6, 11, and 16 weeks after the baseline evalu-
ation. Echocardiograms, VO2 max, and body fat evaluationPeak
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Figure 1 Study design.were recorded at baseline and 16 weeks after the baseline
evaluation.
Of the 24 subjects enrolled in the TRAIN group, 5
subjects were unable to complete the training due to in-
jury or time constraints and withdrew prior to the peak
training data (week 16) collection. Three subjects were
able to complete the peak training data collection, but
were unable to complete the HM due to injury. Thus, a
total of 19 subjects completed the program with peak
training data collected. Of these 19 subjects, 16 subjects
completed the 2007 Miami HM and had blood drawn
within 30 minutes after the race (see Figure 1). Of the
CON group, one individual was unable to continue the
study as a result of scheduling difficulty, leaving a total
of 22 controls that completed all data collection.
Two-dimensional echocardiograms with pulsed-Doppler
imaging were acquired on each subject using a commer-
cial system (Philips HD11). Standard measurements were
performed according to the American Society of Echo-
cardiography guidelines [11]. Interventricular septal wall
thickness, LV internal diameter, and LV posterior wall
thickness were measured in systole and diastole in the
parasternal long axis view. The LV end-diastolic volume,
LV end-systolic volume, stroke volume, and ejection frac-
tion were calculated via modified bi-planer calculation
based on the apical 2 and 4 chamber view. LV mass was
calculated using the area length method. With the pulsed-
Doppler trans-mitral filling velocities (peak early [E’] and
late [atrial-A’]), diastolic function was assessed and an E/A
ratio was determined. One certified echocardiogram tech-
nician was responsible for acquiring all images for each
participant. The measurements and calculations were in-
dependently confirmed by an experienced echocardiog-
rapher. Both were blinded to each subject’s group status.
Blood was collected in EDTA and standard red top
tubes (serum) and processed immediately. Tubes were
immediately centrifuged, and the serum was separated
and stored in a -80° freezer. Serum was analyzed for cTnT
[12], CRP [12], and lipids (HDL, LDL, and TG) [12]. Blood training Echocardiogram, 
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peak training (week 16) using the Ambion LeukoLOCK
system that captured and preserved the blood mono-
nuclear cell layer.
Clinical and biomarker data were analyzed using SPSS
for Windows 15.0 software (SPSS, Inc, Chicago, IL). Fre-
quency and descriptive statistics were calculated to check
all relevant characteristics of the data. Independent
samples t-tests were used to compare baseline variable
differences between the TRAIN and CON groups. Paired
samples t-tests were used to compare changes from base-
line to peak training or baseline to post-HM.
Microarray analysis was performed on blood collected
from each subject at baseline and at 16 weeks. Total
RNA was extracted and analyzed using the Affymetrix
GeneChip Human Gene ST array, which has 28,869
unique genes (or transcripts) which are captured by ~26
probes per gene. Data were normalized using Robust
Multi-Array (RMA) Normalization. Significance Analysis
of Microarray (SAM) Software [13] was used to deter-
mine statistically significant genes that met predeter-
mined False Discovery Rate (FDR) thresholds. SAM uses
non-parametric statistics and gene specific t-tests to
identify statistically significant genes and to measure the
strength of relationships between gene expression and a
specific response variable. SAM also uses permutation
tests to estimate the FDR after accounting for multiple
testing corrections [14]. Genes with FDR p-values < 0.15
and fold-change greater than 1.5 or less than −1.5 were
considered significant. Pathway analysis was conducted
using MetaCore™ (GeneGo, Inc) software.
Two separate gene expression analyses were performed.
The first compared differences in gene expression profiles
between the CON and TRAIN subjects before and after
the HM training. The second analysis focused only on the
TRAIN subjects, by dividing them into high and lowTable 1 Training group and control changes at baseline versu
Training group
Variable Baseline (M±SD) Peak (M±SD) P value
Weight 196.76±28.40 192.85±27.60 0.08
Heart rate 76.71±12.41 67.60±11.76 0.002
Systolic BP (mmHg) 121.62±8.45 114.30±9.23 0.0001
Diastolic BP (mmHg) 80.05±9.70 73.15±8.20 0.007
Relative VO2 max 37.06±7.12 42.02±8.81 0.00004
Body fat (%) 29.51±8.33 28.18±8.86 0.044
HDL 46.71±9.61 43.10±6.37 0.055
LDL 107.05±25.64 103.80±28.03 0.44
Triglycerides 119.90±59.41 116.35±72.01 0.997
CRP 1.92±2.66 1.64±1.92 0.752
Troponin T <0.01 <0.01 0.333
*Difference in variable measures between baseline and peak. **Difference at baselinresponders based on the percent change of their relative
VO2 max (rVO2 max) over the course of the training
program. Relative VO2 max takes into account and in-
dividual’s body weight and is defined as milliliters of
oxygen per kilogram of bodyweight per minute. The
mean percent change in rVO2 max was calculated and
individuals who fell in the upper quartile (upper 25%)
of percent change in rVO2 max were labeled as high-
responders (10 individuals) and those who fell below
the upper quartile were considered low-responders (9
individuals). Gene expression differences between the
two groups were studied at baseline and after the
16 weeks of training.
Results
Of the 16 subjects who completed the HM, the average
time to completion was 2:22:21 (H:Min:Sec), SD = 26:33.
The fastest time was 1:39:00 and the slowest time was
3:11:58. No runner required medical attention after the
race. There were no significant differences between the
TRAIN and CON groups on any baseline characteristics
other than triglycerides, which were significantly higher
(p = 0.03) in the TRAIN group (Table 1).
Comparisons of basic physiological variables were made
from baseline to the peak training time-point (17 weeks)
in both groups (Table 1). VO2 max increased signifi-
cantly (p = 0.00004) among those in the TRAIN group
during the course of the training program. In addition,
the following were significantly decreased: (1) resting
heart rate (p = 0.002), (2) percent body fat (p = 0.044),
and (3) systolic (p = 0.0001) and diastolic (p = 0.007)
blood pressure. Average body weight (p = 0.08) and HDL
(p = 0.055) decreased slightly (p = 0.08), but no other mea-
sured biomarkers (LDL, Tg, CRP, cTnT) showed signifi-
cant improvements. There were no significant changes for
any variables among the CON subjects (Table 1). Table 2s 16 weeks (n=22)
Control group
* Baseline (M±SD) Peak (M±SD) P value* P value**
188.31±26.11 190.11±26.41 .064 0.316
73.18±12.75 76.05±15.99 .357 0.363
116.67±9.86 113.36±7.26 .133 0.088
75.67±8.46 77.14±5.20 .542 0.127
38.83±5.03 39.02±6.74 .813 0.35
26.84±6.84 27.45±6.87 .116 0.256
49.59±7.87 47.05±9.15 .183 0.288
100.23±22.39 105.86±20.61 .087 0.358
85.05±38.84 77.68±40.87 .294 0.03
0.84±0.66 1.03±0.83 .269 0.084
<0.01 <0.01 .333 1
e between Training and Control groups.
Table 2 Echocardiographic changes over 16 weeks (n=19)
Training group Control group
Variable Baseline (M±SD) Peak (M±SD) P value Baseline (M±SD) Peak (M±SD) P value
Interventricular septum in diastole (cm) 0.925±0.102 1.003±0.128 0.028 0.925±0.115 0.982±0.138 0.074
Left ventricular internal diameter in diastole (cm) 4.803±0.490 4.818±0.490 0.864 4.726±0.409 4.876±0.451 0.067
Left ventricular posterior wall in diastole (cm) 0.961±0.092 1.075±0.123 0.003 0.930±0.134 0.963±0.133 0.439
Left ventricular mass (g) 186.6±37.4 209.2±30.0 0.009 183.0±31.1 192.1±32.2 0.114
Left ventricular mass index (g/m2) 91.4±16.8 102.8±12.8 0.008 90.4±15.1 94.2±14.1 0.194
Left ventricular end-diastolic volume (ml) 118.4±23.8 144.1±29.6 0.002 124.7±32.7 133.1±30.8 0.186
Left ventricular end-systolic volume (ml) 45.8±16.4 52.4±16.7 0.195 43.4±14.0 48.0±14.8 0.11
Ejection fraction (%) 61.9±7.9 63.8±7.8 0.461 65.2±6.5 64.2±6.5 0.47
Stroke volume (ml) 72.6±14.0 91.6±20.9 0.001 81.2±22.3 85.1±20.4 0.411
Peak early to late mitral annular velocities (E to A ratio) 1.59±0.37 1.38±0.40 0.03 1.67±0.43 1.70±0.48 0.766
Table 1 shows comparison of echocardiographic changes between TRAIN and CON groups. The following significant changes occurred in the TRAIN group:
(1) interventricular septal thickness increased from 0.925±0.102 cm to 1.003±0.128 cm (p=0.028), (2) posterior wall thickness in diastole increased from
0.961±0.092 cm to 1.075±0.123 cm (p=0.003), (3) LV mass increased from 186.6±37.4 g to 209.2±30.0 g (p=0.009), (4) LV mass index increased from 91.4±16.8 g/m2
to 102.8±12.8 g/m2 (p=0.008), (5) LV end diastolic volume increased from 118.4±23.8 ml to 144.1±29.6 ml (p=0.002), (5) stroke volume increased from 72.6±14.0 ml to
91.6±20. 9ml (p=0.001), and (6) the E to A ratio decreased from 1.59±0.37 to 1.38±0.40 (p=0.03). No significant changes occurred within the control group from baseline
to 16 week follow-up.
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TRAIN and CON groups.
In comparing the gene expression profiles between
TRAIN and CON individuals before training, only 4 genes
(CMKLR1, FOS, IFIT1, and PDK4) showed significant
changes (FC > 1.5, FDR <0.05) (See Table 3). All hadTable 3 Genes with significantly increased expression
levels in active (TRAIN) vs. sedentary (CON) individuals
(FDR <0.05)
Before marathon training - Increased gene expression*
Transcript id Gene Fold change (FC)
7966089 CMKLR1 1.56
7975779 FOS 1.74
7929065 IFIT1 1.51
8141094 PDK4 1.53
After marathon training - increased gene expression*
Transcript id Gene Fold change (FC)
7929256 — 1.6
7928306 — 1.64
7966089 CMKLR1 1.68
7906475 FCRL6 1.66
7996081 GPR56 1.55
7906764 HSPA6 1.53
7964787 IFNG 1.66
8054722 IL1B 1.71
7961175 KLRC3 1.64
7971661 MIR15A 1.8
*FDR= false discovery rate (p<0.05 threshold used).increased levels of gene expression in the TRAIN
group compared to the CON group. No genes were sig-
nificantly decreased.
When comparing profiles from blood collected in
TRAIN and CON individuals after the HM training pro-
gram, ten genes (CMKLR1, FCRL6, GPR56, HSPA6, IFNG,
IL1B, KLRC3, MIR15A) showed significantly elevated ex-
pression (FC > 1.5, FDR < .05) (Table 3) and 53 genes
(including AREG,DEFA3) were found to be significantly
decreased (FC < −1.5, FDR < .05) in the TRAIN group
(Table 4). According to pathway analysis, the biological
pathways that were significantly up-regulated in the
TRAIN individuals after training (p <0.001) were those
involved in inflammatory and immune response, includ-
ing migration inhibitory factor (MIF) in innate immun-
ity response (p = .00014), bacterial infections in normal
airways (p = .0002), apoptosis and survival Nitric Oxide
synthesis and signaling (p = .0002) and bacterial infec-
tions in CF airways (p = .0002) (data not shown). One
biological pathway, translation insulin regulation of
translation (p = .00008), showed significantly decreased
expression in TRAIN individuals after HM training
(data not shown).
The TRAIN group was categorized into 10 high and 9
low responders based on percent change in their rVO2
max. Within the TRAIN group alone, 16 genes showed
trending evidence of decreased expression (FC > −1.5,
FDR < .06) in high vs. low responders, and one gene
showed increased gene expression (FC > 1.5, FDR < .06)
in the high compared to low responders group (Table 5).
Biological processes that were highlighted included those
involved in regulation of DNA transcription, translation
and other metabolic processes.
Table 4 Genes with decreased expression levels in active
(TRAIN) vs. sedentary (CON) individuals
After marathon training - Decreased gene expression
Transcript id Gene Fold change (FC)
8102787 — −1.5
8020825 — −1.7
8037387 — −1.65
8136471 — −1.56
8104490 — −1.56
8084810 — −1.54
8095744 AREG −2.42
8095736 AREG −2.18
8062444 BPI −1.74
7961075 CD69 −1.69
8149116 DEFA3 −2.42
8149126 DEFA3 −2.42
8149137 DEFA3 −2.34
8084704 EIF4A2 −1.7
8158167 LCN2 −1.51
8086607 LTF −1.98
7951246 MMP8 −1.95
8012349 PER1 −1.59
7919269 RNU1-1 −1.55
7919349 RNU1-1 −1.55
7973896 RNU1-1 −1.53
7978568 RNU1-1 −1.53
7898375 RNU1-1 −1.52
7898411 RNU1-1 −1.52
7912800 RNU1-1 −1.52
7912850 RNU1-1 −1.52
7919576 RNU1-1 −1.52
7948894 RNU2-1 −1.53
7938295 RPL27A −1.51
8103975 SLED1 −1.62
7925182 SNORA14B −1.5
7968234 SNORA27 −1.52
7977075 SNORA28 −1.56
7938293 SNORA45 −1.6
8078918 SNORA62 −1.86
8059708 SNORA75 −2.03
8139456 SNORA9 −1.55
7968232 SNORD102 −1.67
8124940 SNORD117 −1.67
7942592 SNORD15A −1.53
8059710 SNORD20 −1.93
7903022 SNORD21 −1.69
Table 4 Genes with decreased expression levels in active
(TRAIN) vs. sedentary (CON) individuals (Continued)
8159004 SNORD24 −1.83
7948906 SNORD27 −1.69
7948904 SNORD28 −1.51
7948900 SNORD30 −1.8
8030364 SNORD34 −1.64
8159006 SNORD36B −1.78
8005951 SNORD42B −1.63
8005957 SNORD4B −1.63
8023259 SNORD58A −1.64
7964246 SNORD59B −1.56
8122265 TNFAIP3 −1.61
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This is the first prospective study evaluating the combin-
ation of changes in cardiac structure and function, periph-
eral blood cell gene expression, inflammatory markers,
and potential for myocardial injury associated with train-
ing for, and performance of, a HM in previously sedentaryTable 5 Genes with significant expression in high
responders* (n=10) vs. low responders** (n=9)
After marathon training - Decreased gene expression
Transcript id Gene Fold change (FC)
7969794 LOC100132099 −1.58
8049530 LRRFIP1 −1.58
7919269 RNU1-1 −1.89
7919349 RNU1-1 −1.89
7898375 RNU1-1 −1.86
7898411 RNU1-1 −1.86
7912800 RNU1-1 −1.86
7912850 RNU1-1 −1.86
7919576 RNU1-1 −1.86
7973896 RNU1-1 −1.85
7978568 RNU1-1 −1.85
7897801 RNU5E −1.89
7920873 SNORA42 −3.49
8117018 — −1.86
7932635 — −1.63
7965150 — −1.62
After marathon training - increased gene expression
Transcript id Gene Fold change (FC)
8005225 LOC162632 2.35
No genes met FDR significance criteria for differential mRNA expression in
blood collected at baseline.
*High Responders are defined as those individuals who fell in the upper
quartile (upper 25%) of percent change in rVO2 max.
**Low Responders are defined as those individuals who fell below the upper
quartile of percent change in rVO2 max.
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rate, and body fat percentage, and the increases in VO2
max, observed in our TRAIN group over the course of the
program are consistent with previously well-documented
responses to exercise training [15,16] and validate the
training effect in our HM participants. More interesting
is the effect of HM training on biomarkers related to
myocardial injury, cardiovascular structural changes by
echocardiogram, serum lipids, gene expression and serum
inflammatory markers.
In our study, LV mass and wall thickness, and LV
end-diastolic and stroke volumes increased significantly
after 16 weeks of training. The E to A ratio also de-
creased throughout training, consistent with a decrease
in diastolic relaxation commonly seen in hypertrophied
ventricles. These echocardiographic changes have been
well-established and recently described to occur in en-
durance athletes in as little as 90 days [17-19]. This
phenomenon, known as the “athlete’s heart,” is thought
to be due to a long-sustained high cardiac output resulting
in a volume-loaded heart that can lead to an increase in
LV cavity, LV mass, and wall thickness [20-22].
Both TRAIN and CON groups had the same inclusion
criteria, which enabled us to maximize the comparison
after training. When comparing gene expression profiles
in blood collected before training in TRAIN versus
CON men, 4 genes showed significant changes in gene
expression (FC = (1.5-1.7) FDR < .05) suggesting that the
two groups were fairly similar before training. Through
pathway analysis, the biological pathways that were
significantly up regulated in the TRAIN individuals
after training were those primarily involved in the body’s
inflammatory and immune response. In looking at the
specific genes involved of the 53 genes that showed sig-
nificantly decreased expression in TRAIN individuals
after training, Amphiregulin (AREG) was most significantly
decreased (FC = −2.42). The protein coded by AREG is a
member of the epidermal growth factor family. AREG
has both growth factor and inhibitory properties (NCBI,
PubMed Gene ID:374). Changes in AREG expression in
human neutrophils have been related to exercise in pre-
vious studies. For example, following 30 minutes of aer-
obic exercise, AREG was shown to increase by 3.4 fold
[23]. Although the change is in the opposite direction of
the change found in the current study this could be due
to the fact that Radom-Aizik et al. [23] examined gene
expression changes following acute exercise, whereas
our focus is on gene expression changes due to long term,
consistent exercise.
Another gene significantly down-regulated in the TRAIN
individuals; defensin, alpha 3, neutrophil-specific (DEFA3)
also has a role in both the immune and inflammatory
response (NCBI, PubMed Gene ID: 1668). A previous
study linked increased expression of DEFA3 at both themRNA and protein level to inflammatory diseases [24].
It is well established that regular exercise helps reduce
the amount of total body inflammation and therefore
helps prevent the induction of many chronic inflamma-
tory diseases including atherosclerosis. A decrease in
total body inflammation is usually associated with a de-
crease in C-reactive protein, which was not observed in
our study. This data suggests that perhaps gene expres-
sion changes associated with a decrease in inflammation
occur prior to changes in cardiac biomarkers or that
subjects with normal CRP at baseline are less likely to
show a measurable response to exercise associated with
changes in gene expression. Perhaps with longer train-
ing, or elevated baseline levels of CPR, similar changes
in the cardiac biomarkers would also be seen.
When comparing the TRAIN high responders and low
responders, several gene expression differences were noted.
Two genes that showed increased expression in high re-
sponders before training included FGFBP2 (FC = 1.76) and
CD160 (FC = 1.55). Both are involved in immune response
(NCBI, PubMED Gene ID: 11126).
Of the genes that showed decreased expression in high
responders after exercise of particular note is LRRFIP1
(FC = −1.57). LRRFIP1 has been identified as having a
role as both a regulator of toll-like receptor pathway sig-
naling and transcriptional repression. Its expression has
been previously shown to be induced by nicotine and
proinflammatory cytokines [25].
Conclusions
In summary, in previously sedentary individuals, intensive
training for a HM over 17 weeks leads to increased cardiac
and hemodynamic performance that is not associated
with longitudinal changes in known cardiac biomarkers.
Elevated cTnT occurred in only 1 of 16 subjects who
completed the HM. Training is also associated with
changes in blood gene expression that reflects the anabolic
state of the body, as well as changes in the body’s immune
and inflammatory response that could be more sensitive
precursors to changes in serum biomarkers. Whereas
some genes involved in the immune/inflammatory re-
sponse showed increased expression, others showed de-
creased expression implying that exercise brings about
changes that both suppress aspects of the immune sys-
tem while stimulating others. Genes with changes in
gene expression as response to HM-training include
AREG, DEFA3, CD160, GPR56, KLRC3, and LRRFIP1.
The results presented here are from a single sample and
do not withstand conservative corrections for multiple
comparisons. The study’s sample is limited to men and
therefore cannot necessarily be generalized to the broader
population which could include females However, they
generate interesting hypotheses about a possible role
of genes involved in immunity and inflammation in
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examination in other data sets.
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